BELLEVUE, Wash.--(BUSINESS WIRE)--CellCyte Genetics Corporation (OTCBB: CCYG) announced today the appointment of Dr. Douglas Pat Cerretti to the position of President effective July 24, 2010. Dr. Cerretti will retain his responsibilities as Chief Science Officer and Director of Business Development. “I am very encouraged by our efforts to engage independent clinical research laboratories to collaborate in the application of CellCyte’s bioreactor product,” said Dr. Cerretti.
